SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Wedbush Raises Biogen Price Target to $225 From $212, Keeps Neutral Rating

Valid market news retained in the public archive without immediate LiveCast distribution.

BIIB

Related stories